MiMedx Group, Inc. Contractual Obligation, to be Paid, Year Five
MiMedx Group, Inc. (MDXG) had Contractual Obligation, to be Paid, Year Five of $0 as of 2019-12-31, per its 10-K filed 2020-07-06.
Discontinued › Notes › Commitment and Contingencies › Contractual Obligation, Fiscal Year Maturity › Contractual Obligation, to be Paid, Year Four and Five
us-gaap:ContractualObligationDueInFifthYear · last filed 2020-07-06
- 2019-12-31: Contractual Obligation, to be Paid, Year Five $0.00.
- 2018-12-31: Contractual Obligation, to be Paid, Year Five $205.00K.
- 2017-09-30: Contractual Obligation, to be Paid, Year Five $1.47M.
- 2017-06-30: Contractual Obligation, to be Paid, Year Five $1.60M.
| Period end | Contractual Obligation, to be Paid, Year Five |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-07-06 |
| 2018-12-31 | $205.00K 10-K · filed 2020-03-17 |
| 2017-09-30 | $1.47M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $1.60M 10-Q · filed 2017-07-31 |
| 2017-03-31 | $1.24M 10-Q · filed 2017-05-01 |
| 2016-12-31 | $141.00K 10-K · filed 2017-03-01 |
| 2014-09-30 | $478.32K 10-Q · filed 2014-11-10 |
| 2014-06-30 | $837.07K 10-Q · filed 2014-08-11 |
| 2014-03-31 | $1.19M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $1.42M 10-K · filed 2014-03-04 |
| 2013-09-30 | $1.41M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $1.36M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $50.00K 10-Q · filed 2013-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |